最高の Rheumatology ポッドキャスト (2024)

1
Ep 15. GUIDELINES - BSR Sjögren disease guideline 2024 15:00

3d ago15:00

15:00

BSR has published an update to the Sjögren disease guideline, expanded to include paediatric and adolescent patients for the first time. Join guideline working group Chair, Liz Price, members Coziana Ciurtin and Benjamin Fisher, and expert by experience member, Bridget Crampton, in a roundtable discussion hosted by Dr Marwan Bukhari. Please note Dr…

1
Ep. 43 The metaverse: a new frontier for rheumatology 11:52

9d ago11:52

11:52

Dr Jason E Liebowitz joins Dr Marwan Bukhari to discuss the metaverse and how the field of rheumatology can utilise virtual and augmented reality to improve the lives of patients. Listen now to hear about the current technological developments and what this means for future clinical practice! You can read this article [https://doi.org/10.1093/rheum…

1
E111: PEXIVAS Subsets with Mike Walsh & Mats Junek 39:27

25d ago39:27

39:27

At ACR23 I had a twitter-disagreement about steroid tapers from PEXIVAS with Mike Walsh, the lead author on the PEXIVAS trial. He kindly agreed to join me for a moderated discussion. Loved hearing his perspective and have to admit he pulled me closer to his practice... but not all the way there. Longer podcast than usual but I prefer to release aud…

1
Ep 29. Cancer treatments and rheumatic disease 29:53

25d ago29:53

29:53

In this episode, Dr Mariam Malik talks to Prof Andrew Cope about cancer treatments and rheumatic disease, covering immune checkpoint inhibitors, the adverse events and rheumatological conditions they can cause, and how to manage them.British Society for Rheumatology による

1
Ep 14. CAREERS - Getting involved in Guidelines 20:24

11d ago20:24

20:24

This podcast gives an opportunity to hear from Dr Caroline Cotton, Lara Chapman and Dr Mark Russell about their experience of authoring guidelines. It covers everything you need to know about BSR guidelines- what they are, insights into the process, how to get involved (including tips for applications) and why you might like to!…

1
E110: Rheum4Debate - Screening for RA-ILD with Joshua Solomon and Scott Matson 24:19

1M ago24:19

24:19

Rheum4Debate is back! In this episode I moderated a debate between two pulmonologists about RA-ILD. As a reminder, Rheum4Debate is an Oxford-style debate show, where two debators disagree over a motion during 3 rounds of discussion. The motion for todays show was: “Asymptomatic patients with rheumatoid arthritis and high risk features for interstit…

1
E109: Abatacept for Pre-RA - the ARIAA Study 16:22

1M ago16:22

16:22

Nice study this week on an important topic. Can we prevent the development of rheumatoid arthritis by initiating DMARDs during a preclinical phase? Lots to discuss: what does it mean to be "pre-clinical?" How does this fit with other studies of this nature? Check it out! https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02650-8/ful…

1
Ep 28. Writing a compelling case report 23:38

2M ago23:38

23:38

In this episode on how to write a compelling case report, Pippa Watson talks to Ai Lyn Tan, an Associate Professor and Honorary Consultant Rheumatologist at Chapel Allerton Hospital Leeds and Editor in Chief of the BSR Rheumatology Advances in Practice journal, and Caroline Groves, our Journal Development Manager at BSR. This podcast covers everyth…

1
E108: Myositis Guidelines for Cancer Screening w/Alexander Oldroyd 16:04

2M ago16:04

16:04

Informative podcast this week with Dr. Alexander Oldroyd, the first author of the recently published "International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening." The article itself appeared in Nature Reviews Rheumatology and provides what I think is a very useful framework for approaching this issue. Article: https://…

1
E107: Fragility of SLE Randomized Controlled Trials 13:17

2M ago13:17

13:17

Quick methodology episode this week discussing the concept of "fragility" in randomized controlled trials of lupus. Really enjoyed discussing this paper and was grateful to have been a part of it. Get the text here: https://lupus.bmj.com/content/lupusscimed/11/1/e001068.full.pdfMichael Putman による

1
Ep 28. NEIAA 23:22

2M ago23:22

23:22

In this episode, Sarah Gallagher talks to Dr Jo Ledingham and Dr Liz Price about all things NEIAA, from changes to data collection, findings from the 5-year report and how data can be used.British Society for Rheumatology による

1
E106: GCA/PMR with Bhaskar Dasgupta 28:28

3M ago28:28

28:28

Today I'm taking another twitter discussion into the podcast realm! Dr. Bhaskar Dasgupta has published hundreds of papers about polymyalgia rheumatica and giant cell arteritis, including a recent publication in Nature Reviews: Rheumatology that piqued my interest (https://www.nature.com/articles/s41584-023-00976-8). In this podcast we discuss scree…

1
Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis? 18:29

3M ago18:29

18:29

Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab. Listen now to hear the findings and what this means for future clinic…

1
E105: Autoimmunity Post COVID-19? 17:41

3M ago17:41

17:41

Interesting topic and interesting paper this year, including discussion of observational biases, positive and negative controls, and interpreting data as it comes. Paper: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2810259Michael Putman による

1
Ep 27. Health disparities 16:28

3M ago16:28

16:28

In this important Talking Rheumatology Spotlight pod we will be talking about health disparities in our Rheumatology services and how we can help tackle them at both an individual and organisational level. Prepare to be inspired. To access the free training click here (120 mins) and the published article here.…

1
Ep 41. Addressing the leaky pipeline 18:32

4M ago18:32

18:32

What is the leaky pipeline and how do we address it? Prof Christina Duftner (University of Innsbruck) and Prof Isabella Grabner (Vienna University of Economics and Business) join Dr Latika Gupta to discuss the diminishing proportion of women in higher ranking and leadership roles within rheumatology. Want to read more? Here's your further reading l…

1
Recent Updates on Management of Uncontrolled Gout, With Drs. Suneet Grewal, Puja Khanna, and Michael Pillinger 24:01

4M ago24:01

24:01

In this podcast, clinical experts discuss key findings presented during the past year on current and emerging therapies for managing uncontrolled gout.

1
Evidence-Based Tools to Detect and Assess Uncontrolled Gout, With Drs. Suneet Grewal, Puja Khanna, and Michael Pillinger 18:04

4M ago18:04

18:04

In this podcast, clinical experts discuss key findings presented during the past year on evidence-based tools for detection and assessment of uncontrolled gout.

1
Burden and Complications of Uncontrolled Gout, With Drs. Suneet Grewal, Puja Khanna, and Michael Pillinger 21:11

4M ago21:11

21:11

In this podcast, clinical experts discuss key findings presented during the past year on disease burden and comorbidities associated with uncontrolled gout.

1
Ep 40. New Editor-in-Chief: Introducing Prof Ernest Choy 5:17

4M ago5:17

5:17

We're delighted to announce Prof Ernest Choy (University of Cardiff) as the incoming Editor-in-Chief of Rheumatology. In this episode, recorded at ACR23, Ernest tells us about his plans for the journal and the type of research he's keen to see. Ernest will take the reins from Dr Marwan Bukhari (Royal Lancaster Infirmary), who finishes his highly pr…

1
E104: Sarilumab for PMR - The SAPHYR Study 18:35

4M ago18:35

18:35

Important trial on the podcast this week! I take a deep dive into the recently published SAPHYR study, which evaluated the use of the IL6 inhibitor sarilumab for patients with PMR. A few aggravating quibbles but overall a very useful trial and an important step forward for patients with PMR. Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2303…

1
Ep.26 Foot pain 29:15

5M ago29:15

29:15

In this episode, Will Gregory talks to Dr Gordon Hendry about all things feet. Essential listening for all of the MDT, this podcast covers everything from the importance of examining feet to the use of ultrasound and the RADAI-F5.British Society for Rheumatology による

1
Ep 39. UK JIA Biologics Register: stopping biologics for remission 10:42

5M ago10:42

10:42

What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register. Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, based at the University of Manchester. Coziana is a …

1
Ep 13. CAREERS - Paediatric rheumatology training 22:53

6M ago22:53

22:53

In this careers pod Dr Diarmuid McLaughlin talks to Dr Sharmila Jandial about training pathways for paediatric rheumatology including tips on finding out more about a career in Rheumatology, training pathways, subspecialty training and where it all can lead. Recommended for anyone thinking of getting involved.…

1
Ep 12. CAREERS - Reasons for choosing rheumatology and different career paths 28:28

6M ago28:28

28:28

In this pod aimed at medical students medical student Edward Mbasoor talks to Associate Professor Ai Lyn Tan about a career in Rheumatology covering all things from; what Rheumatology is, reasons for choosing Rheumatology, career paths and how to find out more about the specialty. A must listen for anyone considering Rheumatology as a career.…

1
Ep 38. Is risankizumab safe and effective for active psoriatic arthritis? Results from the KEEPsAKE 2 study 7:55

6M ago7:55

7:55

Dr Andrew Östör joins Dr Marwan Bukhari to discuss their article, chosen as the June Editor's Choice article, which evaluates the 52-week efficacy and safety of risankizumab 150 mg in patients with active PsA who had previous inadequate response/intolerance to one or two biologic therapies (Bio-IR) or one or more conventional synthetic DMARDs (csDM…

1
E103: Len Calabrese on Monoclonal Antibodies for COVID-19 22:25

6M ago22:25

22:25

This week I took a twitter disagreement from the impersonal world of twitter to the podcast world of a back and forth conversation. Really enjoyed talking to Dr. Len Calabrese about monoclonal antibodies, FDA regulatory pathways, and life in general.Michael Putman による

1
Ep 37. Can MSUS and RADAI-F5 help to identify RA patients at risk of poor functional and radiological outcomes? 13:20

6M ago13:20

13:20

Anika Hoque joins Dr Michael Backhouse to discuss their recent article, which examines the construct validity of the RA foot disease activity index in relationship to musculoskeletal ultrasonography and clinical examination. Listen now to hear the findings, and what this means for future clinical practice and the impact on RA patients at risk for p…

1
E102: Unintentional Unblinding in Rheumatic Disease Trials 11:31

6M ago11:31

11:31

Excited to share an editorial that I wrote along with Cody Bruggemeyer and Desh Nepal, two trainees with me at the Medical College of Wisconsin. We discussed what I believe to be a pervasive (but seldom discussed) issue in rheumatology RCTs: unblinding. I suspect many of our studies suffer from this. Have a listen!…

1
Ep 11. NEIAA year five state of the nation report: Dr Liz Price and Prof James Galloway 11:20

6M ago11:20

11:20

In this episode our guests discuss the National Early Inflammatory Arthritis Audit (NEIAA) year five state of the nation report. Our host, Sarah Gallagher (Project Manager, NEIAA) poses questions to both Dr Liz Price (Clinical Lead, NEIAA) and Professor James Galloway (Lead Methodologist, NEIAA) to explore the report's key findings and the importan…

1
Ep 36. Trainee Publishing Programme 2023: Dr Charlotte Sharp & Karen Staniland 19:38

6M ago19:38

19:38

Can patients with rheumatoid arthritis examine their own joints? Dr David Liew talks to Dr Charlotte Sharp and Karen Staniland about their work to create a video teaching patients how to self-examine tender and swollen joints. Charlotte is now a consultant rheumatologist based in Manchester and has an interest in applied health research. Karen is t…

1
Ep 35. Trainee Publishing Programme 2023: Dr Pallavi Shamdasani 18:43

7M ago18:43

18:43

How can we best diagnose septic arthritis in the acute care setting? Dr Pallavi Shamdasani joins Prof Rene Westhovens to discuss the utility of synovial aspiration and intra-operative synovial fluid and tissue culture for the accurate diagnosis of septic arthritis. Dr Shamdasani is a dual trained rheumatologist and obstetric medicine physician base…

1
Ep.24 Biologics in rheumatology 27:37

7M ago27:37

27:37

This podcast covers everything you need to know about biologics, from choosing to screening, vaccinations and tapering. With thanks to our host, Dr Mariam Malik, and guest, Dr Chris Holroyd, an expert in this area and author of the BSR guideline.British Society for Rheumatology による

1
Ep.25 Accessing and commissioning biologics in paediatric rheumatology 28:14

7M ago28:14

28:14

This podcast covers everything you need to know about accessing and commissioning biologic drugs in Paediatric Rheumatology, with a focus on England. With thanks to our host, Dr Jenny Lemon, and guest, Dr Tavi Aragon, an experienced pharmacist.British Society for Rheumatology による

1
E101: Pred v Colchicine for CPPD: COLCHICORT 10:49

7M ago10:49

10:49

Happy to share the FIRST randomized trial in CPPD today. It's kind of a weird study but worth a quick discussion. https://www.sciencedirect.com/science/article/pii/S2665991323001650Michael Putman による

1
Ep 34. Trainee Publishing Programme 2023: Dr Shivani Gor & Dr Sung-Hee Kim 17:10

7M ago17:10

17:10

What is the relationship between COVID-19 vaccination and disease flares in patients with inflammatory arthritis (IA)? Dr Shivani Gor and Dr Sung-Hee Kim join Dr Mwidimi Ndosi to discuss their retrospective study, which used C-reactive protein as a marker to determine the proportion of IA patients who had a flare within four weeks of receiving a va…

1
Ep 33. Trainee Publishing Programme 2023: Dr Lauren Huckerby 16:53

7M ago16:53

16:53

What evidence is there for effective transitional care in young people with chronic pain, and what should ideal transitional care look like? Dr Lauren Huckerby joins Dr Diederik De Cock to discuss her recent systematic review - one of the winning papers from the 2023 Rheumatology Advances in Practice Trainee Publishing Programme. Dr Huckerby is a p…

1
E100: ADVOCATE Health Related Quality of Life 15:35

7M ago15:35

15:35

This week I dive into the health related quality of life measures that were reported in the ADVOCATE study. I found them overall somewhat convincing and they have affected my practice. Have a listen and be sure to follow along. Find my work at ebrheum.comMichael Putman による

1
Ep 10. CAREERS - A career in research 24:31

7M ago24:31

24:31

In this talking Rheumatology careers pod Dr Anastasia Madenidou talks to Dr Ben Mulhearn about all things research from how to get started in research, to doing a PhD and different ways to incorporate research in consultant jobs.British Society for Rheumatology による

1
Ep 32. Trainee Publishing Programme 2023: Dr Cristiana Sieiro Santos 11:58

7M ago11:58

11:58

Can we classify the clinical phenotype of systemic sclerosis by autoantibodies? Dr Cristiana Sieiro Santos joins Dr Anastasia Madenidou to discuss her recent article - one of the winning papers from the 2023 Rheumatology Advances in Practice Trainee Publishing Programme. Dr Sieiro Santos is currently a rheumatology trainee at Complejo Asistencial U…

1
E99: Hospital Problems 7:29

7M ago7:29

7:29

Quick episode this week from a recent Perspective piece I had published in the New England Journal. Have a listen or a read! https://www.nejm.org/doi/full/10.1056/NEJMp2304828Michael Putman による

1
Ep 31. Are AAV patients at an increased risk of stroke? 8:54

8M ago8:54

8:54

Dr Aladdin J Mohammad joins Dr Marwan Bukhari to discuss their article, chosen as the August Editor's Choice article, which determines the incidence rate, predictors and outcome of stroke in a population-based cohort of individuals with ANCA-associated vasculitis. Listen now to hear the findings and what this means for future clinical practice! You…

1
Ep 23. Antiphospholipid syndrome 26:35

8M ago26:35

26:35

In this episode, Dr Salema Khalid talks to Prof Anisur Rahman about antiphospholipid syndrome, covering tests, treatment and management, including in pregnancy.British Society for Rheumatology による

1
Updates on Emerging Options for PrEP and COVID-19 Management in Immunocompromised Patients, With Drs. Leonard Calabrese and Kevin Winthrop 17:56

8M ago17:56

17:56

In this podcast, expert clinicians will discuss the current tools available for outpatient management of COVID-19 and provide updates on emerging options for preexposure prophylaxis.

1
Ep 30. Diagnosing cocaine-induced vasculitis 13:10

8M ago13:10

13:10

How can you differentiate between cocaine-induced and ANCA-associated vasculitis? Dr Sander van Leuven joins Dr David Liew to discuss a recent case series analysis from centres in Birmingham and London. Sander is a consultant rheumatologist in Nejmegen, the Netherlands. He previously trained in London, where he conducted a 15-year retrospective stu…

1
E98: Key Opinion Leaders & ILD Guidelines 10:29

8M ago10:29

10:29

Podcast this week discussing key opinion leaders (KOLs) and pharmaceutical companies. Please subscribe to my newsletter (ebrheum.com) and be sure to share the podcast with friends!Michael Putman による

1
Ep 22. Pain 31:04

8M ago31:04

31:04

In this episode, Will Gregory talks to Dr Nick Shenker about different types of pain that affects patients, including looking at how to approach assessment and treatment, tips on managing pain, and providing helpful resources and guidance for listeners.British Society for Rheumatology による

1
Ep 29. Does vaccination against SARS-CoV-2 infection cause adverse events among SLE patients? 14:57

9M ago14:57

14:57

Dr Ioannis Parodis and Dr Elena Nikiphorou join Dr Eunice Co to discuss their findings in the COVAD study of the safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus. Listen now to hear the results of a study involving 9462 participants and 106 investigators in 94 countries! You can read this article [https:…

1
BONUS CASE. AxSpA case discussion 22:41

9M ago22:41

22:41

In this case-based spotlight episode, Professor Karl Gaffney discusses a case of axial spondyloarthropathy with Dr Ash Elliot sharing tips for diagnosis and management.British Society for Rheumatology による

1
Outpatient Management of COVID-19 in Immunocompromised Patients: Educating the Patient, With Drs. Leonard Calabrese and Cassandra Calabrese 14:30

9M ago14:30

14:30

In this podcast, expert clinicians will discuss current unmet needs regarding patient education and review strategic messaging to enhance the preparedness of immunocompromised patients at risk for COVID-19.

聞く価値のあるポッドキャスト

ポッドキャスト Rheumatology

聞く価値のあるポッドキャスト

クイックリファレンスガイド